CLASS II Drug recall · Reported 22 Jan 2014 · FDA Enforcement Report
Venlafaxine HCL Tablet, 50 mg recalled by Aidapak Services
Aidapak Services is recalling Venlafaxine HCL Tablet, 50 mg, distributed in Arizona, California, Oregon, Washington. The recall was initiated on 2 Jul 2013 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-534-2014
- FDA event ID
- 65707
- Recalling firm
- Aidapak Services, Vancouver, WA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 2 Jul 2013
- FDA classified
- 16 Jan 2014
- Reported
- 22 Jan 2014
- Type
- Voluntary: Firm initiated
- Customers notified by
- Telephone
- Reason category
- Labeling Errors
- Drug class
- Antidepressants
Timeline
| 2 Jul 2013 | Recall initiated by company | |
| 16 Jan 2014 | Classified by FDA | +198 days |
| 22 Jan 2014 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Label Mixup; VENLAFAXINE HCL Tablet, 50 mg may be potentially mislabeled as sulfaSALAzine, Tablet, 500 mg, NDC 00603580121, Pedigree: AD65475_19, EXP: 5/28/2014.
Product as listed by the FDA
VENLAFAXINE HCL Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155024801
Where it was distributed
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Questions about this recall
Is Venlafaxine HCL Tablet, 50 mg recalled?
Yes. Aidapak Services recalled Venlafaxine HCL Tablet, 50 mg on 2 Jul 2013. The recall is Class II and its status is Terminated. Recall number D-534-2014.
Why was it recalled?
Labeling: Label Mixup; VENLAFAXINE HCL Tablet, 50 mg may be potentially mislabeled as sulfaSALAzine, Tablet, 500 mg, NDC 00603580121, Pedigree: AD65475_19, EXP: 5/28/2014.
Which lots are affected?
VENLAFAXINE HCL Tablet, 50 mg has the following code Pedigree: AD65475_22, EXP; 5/28/2014.
Where was it sold?
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Aidapak Services
All 538| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | MERCapsuleTOPURINE, Tablet, 50 mg recalled by Aidapak Services | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Selenium, Tablet, 50 mcg, Over The Counter recalled by Aidapak Services | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Venlafaxine HCL, Tablet, 100 mg recalled by Aidapak Services | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Ascorbic Acid, Tablet, 500 mg, Over The Counter recalled | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Calcitriol, Capsule, 25 mcg recalled by Aidapak Services | Aidapak Services | Packaging Defects | 4 states |
Other Venlafaxine recalls
All 19| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Venlafaxine Tablets, USP, 75 mg recalled by Zydus Pharmaceuticals (USA)Venlafaxine | Zydus Pharmaceuticals (USA) | Foreign Material | Nationwide |
| Drug | CLASS III | Venlafaxine Extended-Release Tablets, 150mg recalled by Appco PharmaVenlafaxine | Appco Pharma | Other | Nationwide |
| Drug | CLASS II | Venlafaxine Hydrochloride Extended-Release Capsules, USP 5mg recalledVenlafaxine Hydrochloride | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
| Drug | CLASS II | Venlafaxine Tablets, USP 50 mg* recalled | Sun Pharmaceutical Industries | Other | TN |
| Drug | CLASS II | Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg recalled | Lucid Pharma | Packaging Defects | Nationwide |